Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.


Updates from The Motley Fool

Latest updates on Abbott Laboratories from Fool.com.  The Fool has written over 700 articles on Abbott Laboratories.
3 Top Dividend Stocks to Buy Now

Image source: Getty Images. As the British saying goes, mighty oaks from little acorns grow, a ma...

Why Alere Inc. Climbed 21% Today

IMAGE SOURCE: ABBOTT LABS. What:  News of a Justice Department investigation of billing practices...



Stock Performance

View Interactive ABT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Abbott Laboratories.
Current Price: $38.60
Prev Close: $38.43
Open: $38.44
Bid: $38.58
Ask: $38.59
Day's Range: $38.22 - $38.59
52wk Range: $36.00 - $46.22
Volume: 2,695,893
Avg Vol 8,478,331
Market Cap: $58B
P/E (ttm): 58.23
EPS (ttm): $0.66
Div & Yield: $1.04 (2.7%)

Company Rating

What our community thinks about Abbott Laboratories.
CAPS Rating 5 out of 5
 
2483 Outperform
96 Underperform
CAPS All Stars
 
569 Outperform
14 Underperform

How do you think Abbott Laboratories will perform against the market?



You pick for Abbott Laboratories is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Miles D. White, CEO

80% Approve

Based on 495 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Abbott Laboratories.

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers